Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus

LEXINGTON, Mass., Charlotte, N.C., United States:   Tanner Pharma, a global provider of specialty medicine access solutions, today announced a collaboration

READ MORE

Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider

Bio Vitos Pharma AB (publ) (”Bio Vitos”) has entered into a liquidity provider agreement with Lago Kapital (”LAGO”).  According to

READ MORE

Dicot Pharma listed on Nasdaq First North

After six years on Spotlight Stock Market, the pharmaceutical company Dicot Pharma is moving to Nasdaq First North. The first day

READ MORE

DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed

The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 7 October 2024 has been

READ MORE

Mankind Pharma gets CCI nod for BSV acquisition

Mankind Pharma logo. File | Photo Credit: Reuters Mankind Pharma Ltd. said it had obtained regulatory approvals including the approval from the Competition Commission of

READ MORE

CCI approves acquisition of Bharat Serums and Vaccines Limited by Mankind Pharma Ltd.

CCI approves acquisition of Bharat Serums and Vaccines Limited by Mankind Pharma Ltd. Source link

READ MORE

Brinton Pharma Unveils UV DOUX Lightening Balm with SPF 40

BRINTON, a renowned name in skincare innovation, proudly announces the launch of its latest product – UV DOUX Lip Lightening Balm in India. Specially

READ MORE

Enorama Pharma AB (publ) Explores Divestment of Nicotine Replacement Therapy Chewing Gum Business

The board of directors at Enorama Pharma AB (“Enorama Pharma” or the “Company”) has decided to explore the possibility of

READ MORE

PCI Pharma Services Invests Over $365 Millionin EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products

Philadelphia, United States:   PCI Pharma Services, (“PCI”)a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex

READ MORE

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”),

READ MORE